Biologicals such as monoclonal antibodies and recombinant proteins are produced in cultured cell lines from humans, lower mammals, insects, and bacteria. These therapeutic producing cells are typically created through a process that involves:
While in culture, these cells must be passaged regularly increasing the chance of genetic alteration, contamination, or loss of expression constructs as the cells divide. Thus, for optimal drug production, it is critical that cells are passaged as few times as possible and that the original high producing clone is not lost or altered.
A master cell bank is created from the original therapeutic-producing cell and cryopreserved in multiple vials to prevent genetic variation and potential contamination by eliminating the total number of times a cell line is passaged or handled during the manufacturing process.
To see BioReliance’s cell banking services, use the search tool above or click here.
Apps, Tools, Newsletters & More...
Find the latest scientific resources from Sigma-Aldrich.
Copyright © 2017 Sigma-Aldrich Co. LLC. All Rights Reserved. Reproduction of any materials from the site is strictly forbidden without permission. Sigma-Aldrich brand products are sold exclusively through Sigma-Aldrich Co. LLC. Sigma-Aldrich Corp. is a subsidiary of Merck KGaA, Darmstadt, Germany Terms | Privacy | Site Map